Combination potential: These medications arent mutually exclusive
Complementing randomized trial evidence, extensive real-world observational data from large healthcare databases consistently demonstrate associations between GLP-1 receptor agonist utilization and decreased risks of MALOs involving cirrhosis, hepatic decompensation, HCC, and death from hepatic causes in patients with MASLD and type 2 diabetes
Reviewing data on 9,341 obese or overweight patients treated in 37 studies with any of 18 different weight-loss medications, researchers found they regained on average nearly one pound (0.4 kg) per month after stopping the drugs, and were projected to return to pre-treatment weight by 1.7 years
Although manufacturers may be aware of some of these risks, some risks may have been under-reported or explained in order to keep profits up despite the harm they cause to people
"If your goal is skin tone and radiance, that range moves up toward 500 to 1,000 milligrams a day." Anywhere between 250 milligrams and 1,000 milligrams is the sweet spot, according to most experts